Mitesh Parekh


Job title: Account Manager


Advancing Neurodegenerative Drug Discovery with a New Class of Consistent, Scalable Human iPSCDerived cells 12:30 pm - 1:40 pm

Discovering how next generation precision reprogramming technology, opti-ox(TM), is overcoming the inefficiencies and inconsistencies of current cell generation methods  Understanding how precision reprogramming is powering a new class of rapidly maturing, consistent and scalable human iPSC-derived cells (glutamatergic neurons, GABAergic neurons and microglia) and associated disease models for neurodegenerative disorders such as Gaucher’s, Huntington’s and…Read more

day: Track A - Day 1 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.